Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease

Clinical and Translational Gastroenterology

Volumn 5, Issue 1, 2014, Pages

  Dhillon, Sandeep S ^a,b   Mastropaolo, Lucas A ^a   Murchie, Ryan ^a   Griffiths, Christopher ^a   Thöni, Cornelia ^a,c   Elkadri, Abdul ^a,b   Xu, Wei ^d   Mack, Amanda ^e   Walters, Thomas ^a,b   Guo, Conghui ^a   Mack, David ^e   Huynh, Hien ^f   Baksh, Shairaz ^f   Silverberg, Mark S ^b,d   Brumell, John H ^a,b   Snapper, Scott B ^g,h   Muise, Aleixo M ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF TORONTO   (Canada)

^e CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^f STOLLERY CHILDREN S HOSPITAL   (Canada)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; NITROSATIVE STRESS; NOS2 GENE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INJURY; ULCERATIVE COLITIS; VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE;

EID: 84911206728     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2013.17     Document Type: Article

References (34)

1. Levine A, Griffiths A, Markowitz J et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17: 1314-1321.
2. Van Limbergen J, Russell RK, Drummond HE et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008; 135: 1114-1122.
3. Ruemmele FM, El Khoury MG, Talbotec C et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatric Gastroenterol Nutr 2006; 43: 603-609.
4. Heyman MB, Kirschner BS, Gold BD et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146: 35-40.
5. Heyman MB, Kirschner BS, Gold BD et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146: 35-40.
6. Kugathasan S, Baldassano RN, Bradfield JP et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008; 40: 1211-1215.
7. Imielinski M, Baldassano RN, Griffiths A et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009; 41: 1335-1340.
8. Muise AM, Snapper SB, Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology 2012; 143: 285-288.
9. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-2078.
10. Guihot G, Guimbaud R, Bertrand V et al. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Amino Acids 2000; 18: 229-237.
11. Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 179-189.
12. McCafferty DM. Peroxynitrite and inflammatory bowel disease. Gut 2000; 46: 436-439.
13. Muise AM, Walters T, Xu W et al. Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. Gastroenterology 2011; 141: 633-641.
14. Muise AM, Xu W, Guo CH et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2012; 61: 1028-1035.
15. Uto T, Contreras MA, Gilg AG et al. Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. Dev Neurosci 2008; 30: 410-418.
16. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001; 23: 291-299.
17. Sherlock M, van den Heuvel M, Walters T et al. Phenotypic evolution of pediatric inflammatory bowel disease using the new paris classification. Gastroenterology 2011; 140: S-90; S-91.
18. Martin MC, Martinez A, Mendoza JL et al. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics 2007; 59: 833-837.
19. Mannick JB, Asano K, Izumi K et al. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79: 1137-1146.
20. Dixon AL, Liang L, Moffatt MF et al. A genome-wide association study of global gene expression. Nat Genet 2007; 39: 1202-1207.
21. Jostins L, Ripke S, Weersma RK et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124.
22. Franke A, McGovern DP, Barrett JC et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-1125.
23. Anderson CA, Boucher G, Lees CW et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246-252.
24. Lees CW, Barrett JC, Parkes M et al. New IBD genetics: common pathways with other diseases. Gut 2011; 60: 1739-1753.
25. Karasneh JA, Darwazeh AM, Hassan AF et al. Association between recurrent aphthous stomatitis and inheritance of a single-nucleotide polymorphism of the NOS2 gene encoding inducible nitric oxide synthase. J Oral Pathol Med 2011; 40: 715-720.
26. Johannesen J, Pie A, Pociot F et al. Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes. J Clin Endocrinol Metab 2001; 86: 2792-2796.
27. Mori M. Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J Nutr 2007; 137: 1616S-1620S.
28. Lewis ND, Asim M, Barry DP et al. Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J Immunol 2010; 184: 2572-2582.
29. Lewis ND, Asim M, Barry DP et al. Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II. J Immunol 2011; 186: 3632-3641.
30. Benchimol EI, Fortinsky KJ, Gozdyra P et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-439.
31. Benchimol EI, Guttmann A, Griffiths AM et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009; 58: 1490-1497.
32. Glocker EO, Kotlarz D, Boztug K et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361: 2033-2045.
33. Moran CJ, Walters TD, Guo CH et al. IL-10R polymorphisms are associated with veryearly- onset ulcerative colitis. Inflamm Bowel Dis 2012; 19: 115-123.
34. Blaydon DC, Biancheri P, Di WL et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 2011; 365: 1502-1508.